Skip to main content

Identification and pathogenicity of hepatitis E Virus from laboratory Bama miniature pigs

Abstract

Background

Hepatitis E virus (HEV) genotypes 3 and 4 are zoonotic. In this study, HEV infection in laboratory Bama miniature pigs in Sichuan Province of China was investigated. Firstly, one hundred rectal swabs were collected for HEV RNA testing, and chose positive samples for sequence analysis. Concurrently, for pathogenicity study, six healthy Bama miniature pigs were randomly divided into two groups of 3 pigs each. A total of 500 μL of HEV stock (positive fecal samples identified in this study) was inoculated intravenously into each pig in the experimental group, and the three pigs in the other group served as negative controls. Serum and fecal samples were collected at 1 to 10 weeks post-inoculation (wpi) for alanine aminotransferase (ALT) levels, anti-HEV antibodies and HEV RNA detection, respectively. During necropsies, liver lesions and HEV antigen in liver were observed at 10 wpi.

Results

The rate of fecal sample HEV RNA-positivity was 12% (12/100). Sequence comparisons indicated that partial ORF1 and ORF2 gene sequences of this isolate shared highest identities with corresponding sequences of genotype 4a HEV isolates (81.4%-96.1% and 89.9%-97.1%, respectively). Phylogenetic tree analysis further demonstrated that sequences of this isolate clustered together with sub-genotype 4a HEV isolate sequences. Experimentally, the pathogenicity of Bama miniature pigs infected with this isolate exhibited viremia, fecal virus shedding, seroconversion, ALT level increasing, liver lesions and HEV antigen in liver.

Conclusions

This is the first study to confirm that HEV is currently circulating in laboratory Bama miniature pigs in China and this isolate can successfully infect Bama miniature pigs experimentally. More importantly, this study suggested HEV screening of laboratory pigs should be conducted to prevent research personnel from acquiring zoonotic HEV infections.

Peer Review reports

Background

Hepatitis E virus (HEV) is a quasi-enveloped, single-stranded positive-sense RNA virus belonging to the family Hepeviridae [1]. This family contains two genera: Orthohepevirus (mainly mammalian hosts) and Piscihepevirus (cutthroat trout virus), with the former comprised of four species designated A-D [2]. The species Orthohepevirus A is classified into eight genotypes (HEV-1 through HEV-8) [3]. HEV-1 and HEV-2 are exclusively infectious to humans [4]. HEV-3 and HEV-4 are zoonotic (isolated from humans, swine, rabbits, cows, sheep, mongooses and deer) [5], while HEV-5 and HEV-6 mainly circulate in wild boars [6, 7] and HEV-7 and HEV-8 circulate in dromedary and Bactrian camels [8, 9], respectively. In China, the predominant HEV genotype detected in recent years, HEV-4, has been shown to spread via zoonotic transmission [10], and six subtypes of HEV-4 (4a, 4b, 4d, 4g, 4h and 4i) have been detected in humans and animals [10,11,12,13].

Lacking an efficient cell culture system, the process of studying HEV has been hampered in HEV propagation [14]. Researchers have had to use animals, such as non-human primates, swine, rabbits, mice and rats for most studies [15,16,17]. However, investigations based on rabbit, mouse and rat models have disadvantages when used to study clinical manifestations of HEV infection, while high costs, operational challenges and labor-intensive resource needs have limited the use of non-human primate and conventional swine models for such studies [18, 19]. Bama miniature pigs have served as a genetically stable, highly inbred, easily handled and low cost viable infection model that are currently used extensively in research, especially in long-term trials [20, 21]. Notably, recent studies have demonstrated that these animals are susceptible to experimental HEV infection and laboratory pigs harbor anti-HEV antibodies [14, 20], although HEV RNA detection in laboratory Bama miniature pig has not been reported to date. Based on these findings, this study was to investigate whether HEV is circulating in laboratory pigs.

Results

Amplification, comparisons and phylogenetic analysis of the partial ORF1 and ORF2 genes of HEV

The HEV RNA positivity rate was 12% (12/100) for the set of fecal samples that were collected from laboratory Bama miniature pigs. Firstly, a 280-bp region (primer binding sites were excluded) of the HEV ORF1 gene sequences were analyzed. The 12 sequences of this region shared 100% identity with each other and 67.5%-90.4% identity with other HEVs, with higher identity shared with isolates of known genotype 4 HEV strains and highest identity with genotype 4a sub-genotype isolates (86.1%-90.4%, Table 1). Meanwhile, similar results were obtained for the partial ORF2 gene: the 306-bp sequences shared 100% identity with each other and 76.1%-97.1% identity with other HEVs, with higher identity shared with known genotype 4 HEV isolates than other genotypes and highest identity shared with sub-genotype 4a isolates (89.9%-97.1%, Table 1).

Table 1 Comparisons of the CHN-SC-BMP1 (ORF1) and CHN-SC-BMP2 (ORF2) sequences obtained in the present study with the corresponding region of reported different HEV isolates in GenBank

Further phylogenetic tree analysis of 30 genomes of HEV1-HEV4 strains and the strain detected in this study confirmed this isolate belonged to genotype 4 HEV (Fig. 1). Meanwhile, according to the sequences of CHN-SC-BMP1 (ORF1) and CHN-SC-BMP2 (ORF2), this isolate was also confirmed to cluster with sub-genotype 4a HEV isolates (Fig. 1).

Fig. 1
figure 1

Phylogenetic tree based on the partial sequences of ORF1 (A) and ORF2 (B) obtained from Bama miniature pig feces. The phylogenetic tree was inferred by the neighbor-joining method (1,000 bootstrap replicates) using the MEGA 7 program. Sequences of CHN-SC-BMP1 (ORF1) and CHN-SC-BMP2 (ORF2) are labeled with “

Seroconversion, viremia, fecal virus shedding, and ALT levels in the experimentally infected pigs

In the inoculated group, all pigs seroconverted (cut-off value was 0.357) at 2 week post inoculation (wpi) and then reached a peak level (4-5 wpi) (Fig. 2A), and at the ends of the experiment, pigs were still positive (10 wpi) (Fig. 2A). In contrast, all control pigs were seronegative throughout the study (Fig. 2B). The fecal and serum samples from all pigs were negative for swine HEV RNA at pre-inoculation, and pigs remained negative throughout the experiment in the negative control group (Fig. 2B). Fecal virus shedding and viremia were first detected in all inoculated pigs at 1 wpi (Fig. 2A). Meanwhile, HEV RNA was detectable in fecal samples until 10 wpi in all pigs and was detected in serum samples for 7-8 weeks (Fig. 2A).

Fig. 2
figure 2

Fecal viral shedding / viremia, ALT levels, and antibody levels in pigs experimentally inoculated with the virus isolated in this study. (A) Inoculated group; (B) Negative control group. “+” and “-” represent positive and negative for fecal virus shedding and viremia, respectively. Detection of swine HEV RNA using RT-nPCR.

During the entire study, there was no elevation of ALT levels in serum samples in negative control group (Fig. 2B). While ALT levels transiently increased (92-102 U/L) at 1 wpi and then returned to baseline levels in all inoculated pigs (Fig. 2A). Meanwhile, the increasing ALT levels from inoculated pigs were higher than the ones in negative control group at 1 wpi, but not at other wpi.

Histopathological and immunohistochemical changes in liver tissues

Microscopically, all pigs in the negative control group had no hepatic lesions (Fig. 3A), while all inoculated pigs showed local lymphocytic portal phlebitis in the livers (Fig. 3B). With IHC staining, no specific brown staining was observed in the livers of all uninoculated pigs (Fig. 3C), and HEV antigens were detected in the inoculated group (Fig. 3D).

Fig. 3
figure 3

Microscopic lesions and HEV antigens detection in the liver from the necropsied pigs. (A) Liver sections from pigs in negative control group showing no visible pathological signs of HEV infection; (B) Local lymphocytic venous periphlebitis (arrow) in inoculated pigs; (C) Liver sections from pigs showing no specific brown staining in negative control group; (D) HEV antigens in the livers (arrow) of all inoculated pigs

Discussion

At present, non-human primates, including swine, rabbits, mice and rats, usually served as experimental subjects in most HEV studies [15,16,17], but all these animal models have shortcomings [18, 19] . By contrast, Bama miniature pigs are an ideal infection model used extensively in research, especially for long-term trials [20, 21]. In previous studies, antibodies specific for HEV have been detected in laboratory Bama miniature pigs, an animal host also known to be susceptible to experimental HEV infection [14, 20]. The results in this study showed that HEV RNA positivity rate was 12% (12/100) from collected fecal samples of laboratory Bama miniature pigs in Sichuan Province, and the partial ORF1 and ORF2 gene sequences of this isolate shared highest identities with corresponding sequences of genotype 4a HEV isolates, respectively. The pathogenicity of this isolate in Bama miniature pigs was characterized by emerged viremia, fecal virus shedding, seroconversion, ALT level increasing, liver lesions and HEV antigen in liver. This is the first study to detect HEV RNA in fecal samples from laboratory Bama miniature pigs, and this HEV strain can successfully infect Bama miniature pigs experimentally.

In China, HEV-4 has been shown the predominant circulating genotype in recent years, and six subtypes of HEV-4 (4a, 4b, 4d, 4g, 4h and 4i) have been detected in humans and animals [10,11,12,13]. Interestingly, research had shown that HEV-4 subtype distribution varied among different region in China: HEV-4a was the predominant subtype in humans and pigs in eastern China, while HEV-4b was in southern China [22]. In the present study, this HEV strain from laboratory Bama miniature pigs in southwestern China belonged to HEV-4a genotype. Importantly, this finding suggests that HEV-4a may circulate currently in laboratory Bama miniature pigs in this region, and more epidemiological research needs to be done to confirm this hypothesis in future studies.

In the experimental inoculation study, all inoculated pigs exhibited viremia, fecal virus shedding, seroconversion, increasing ALT level, liver lesions and HEV antigen in liver, and the pathogenicity was similar as swine HEV inoculated Bama miniature pigs as previously described [20]. However, there were obvious differences between these two findings for the time of viremia, fecal virus shedding and seroconversion, the experimental pathogenicity study showed that the virus in pigs lasted until 10 weeks, which was longer than previous study [20]. The main reason for this difference was the virus doses dependent as well as the various genotypes of swine HEV. Meanwhile, there is an oscillation of the RNA detection in blood and stools in inoculated group, which have been also found in previous studies [17, 23]. The possible reason is that the sensitivity of the RT-nPCR assays affected the results. It is well-known that swine HEV-4 is zoonotic and can infect cynomolgus macaques, rabbits, BALB/c mice and humans [17, 22, 24, 25]. Therefore, HEV screening of laboratory Bama miniature pigs should be conducted as a precautionary measure to reduce risk of zoonotic HEV transmission from pigs to laboratory personnel in the work environment.

Conclusion

Collectively, our results show that HEV is currently circulating in laboratory Bama miniature pigs in China and this isolate can successfully infect Bama miniature pigs experimentally. More importantly, our findings emphasize that HEV screening of laboratory Bama miniature pigs should be performed to ensure the usefulness of this model for studying clinical manifestations of HEV, and also preventing zoonotic HEV transmission from pigs to research personnel.

Methods

Clinical sample collection and processing

In December 2020, one hundred rectal swabs were collected from Bama miniature pigs at a laboratory animal center in Sichuan Province, southwest China. Each sample was diluted in phosphate-buffered saline to generate a 10% (w/v) fecal homogenate suspension, followed by clarification of suspensions via centrifugation at 4500 × g for 10 min at 4 °C.

Amplification of the partial ORF1 and ORF2 genes of HEV

200 μL of 10 % fecal suspension was used for total RNA extraction by TRIzol Reagent (TaKaRa, China). All samples were analyzed using a broad-spectrum nested reverse transcription polymerase chain reaction (RT-nPCR) with specific primers designed to amplify the partial RdRp region of HEV ORF1 gene, which were described previously by Reimar Johne [26]. In addition, to confirm detection of HEV, the partial ORF2 gene of the HEV genome was also amplified using RT-nPCR as described previously [27]. Briefly, for RT-nPCR, reverse transcription and first PCR were performed using PrimeScript™ One Step RT-PCR Kit (TaKaRa, China). Next, the second PCR was conducted using TransTaq High Fidelity DNA polymerase (TransGen Biotech, China) based on the manufacturer’s instructions. Finally, PCR products were identified by electrophoresis on 1% agarose gel. To avoid cross-contamination, the negative controls were set up in all of these experiments, and filter tips were also used throughout the process. All purified positive PCR products were sequenced by Genetic Analyzer(ABI 3130, Applied Biosystems, USA). Two sequences were submitted to GenBank (Accession numbers MW498242 and MW498243).

Sequence analysis

Based on sequences that were obtained, multiple alignments were performed using the MegAlign program within the Lasergene software package (Version:7.1.0, DNASTAR Inc., Madison, WI). Next, phylogenetic trees were constructed that also incorporated other known GenBank HEV strain sequences using the MEGA7 software. GenBank numbers included D10330, D11092, D11093, KX578717, FJ527832, AY115488, AP003430, AB197673, EF077630, EU366959, KC492825, MK410045, DQ279091, EU676172, AB074915, AB200239, AY594199, FJ610232, GU206559, GU361892, KF176351, AY723745, AB220974, AB108537, GU119961, GU188851, AB369690, DQ450072 and HM439284.

Animal experiment design and samples collection

Six healthy Bama miniature pigs (body weight, 5 kg) were randomly divided into two groups of 3 pigs each, and were monitored for 2 weeks to ensure negative HEV RNA and antibody test before challenged. The virus (a pool of HEV-4a from faeces of all HEV positive Bama pigs analyzed earlier) was quantitatively analyzed by RT-nPCR as previously described [28] and the titer of this infectious stock was 106 genome equivalents per ml (106 GE/ml). A total of 500 μL of this stock was inoculated intravenously into each pig in the experimental group, and the three pigs in the other group served as negative controls. Fecal and serum samples were collected from each pig before inoculation and weekly thereafter. Serum samples were tested for alanine aminotransferase (ALT) levels and anti-HEV antibodies. Fecal and serum samples were also tested for HEVs RNA by RT-nPCR. After pigs were necropsied at 10 wpi, liver samples were collected and fixed in 10% neutral buffered formalin for histological examination and immunohistochemistry (IHC).

Detection of anti-HEV antibodies , ALT concentrations and swine HEV RNA

Anti-swine HEV IgG antibodies were tested in serum samples by indirect ELISA as previously described [12]. Briefly, purified CHN-SD-sHEV truncated capsid protein (200 ng/well) was coated on the plates overnight at 4°C. After blocked and washed, serum samples (1:100, 100 μL/well) were added into each well and incubated for 1 hour at room temperature (RT). After washed, horseradish peroxidase (HRP)-conjugated goat anti-swine IgG (Jackson ImmunoResearch, West Grove, PA, USA) (1:5000, 100 μL/well) was added and also incubated for 1 hour. After washed again, 3,3´,5,5´-tetramethylbenzidine (TMB) was added and the plates were incubated in the dark for 15 min at RT. The colorimetric reaction was stopped (3 M H2SO4, 50 μL/well) and optical density (OD) values were read at 450 nm by an automated microplate reader (Bio-Rad, USA). Each sample was detected in duplicate wells.

ALT concentrations in plasma samples from pigs were measured using standard methods on a SmartSpec 3000 spectrophotometer. Before challenged, the serum sample was collected weekly for three times from each pig and the average ALT baseline was 38 U/L (physiological ALT range: 32-44 U/L). Pigs were considered positive for hepatitis, when their ALT levels exceeded pre-challenge ALT levels more than two-fold [29].

The partial ORF2 gene of swine HEV RNA was amplified from 200 μL 10 % fecal suspension or 200 μL sera from inoculated pigs were tested according to the same method as described above.

Evaluation of histopathological and immunohistochemical changes in liver tissues

During necropsies, the liver tissues were harvested separately and fixed for routine histological examination. IHC analyses were conducted using an UltrasensitiveTM SP kit and a DAB Detection Kit (Fuzhou Maixin Biotechnology Development Co., China) based on the manufacturer’s instructions. The monoclonal antibody 3E8 (mouse anti-HEV capsid protein, 1mg/ml, 1:1,000 dilution) was used.

Availability of data and materials

The datasets generated and/or analysed during the current study are available in the [NCBI] repository, [ACCESSION NUMBERS MW498242 and MW498243]”.

Abbreviations

HEV:

Hepatitis E virus

ELISA:

Enzyme-linked immunosorbent assay

ORF:

Open Reading Frame

RT-nPCR:

Reverse Transcription-nested Polymerase Chain Reaction

wpi:

Week post inoculation

IHC:

Immunohistochemistry

References

  1. Meng XJ. Zoonotic and foodborne transmission of hepatitis E virus. Semin Liver Dis. 2013;33:41–9.

    CAS  Article  Google Scholar 

  2. Smith DB, Simmonds P, Members Of The International Committee On The Taxonomy Of Viruses Hepeviridae Study G, et al. Consensus proposals for classification of the family Hepeviridae. J Gen Virol. 2015;96:1191–2.

    CAS  Article  Google Scholar 

  3. Smith DB, Izopet J, Nicot F, Simmonds P, Jameel S, Meng XJ, et al. Update: proposed reference sequences for subtypes of hepatitis E virus (species Orthohepevirus A). J Gen Virol. 2020;101:692–8.

    CAS  Article  Google Scholar 

  4. Escriba JM, Nakoune E, Recio C, Massamba PM, Matsika-Claquin MD, Goumba C, et al. Hepatitis E, Central African Republic. Emerg Infect Dis. 2008;14:681–3.

    Article  Google Scholar 

  5. Yugo DM, Meng XJ. Hepatitis E virus: foodborne, waterborne and zoonotic transmission. Int J Environ Res Public Health. 2013;10:4507–33.

    Article  Google Scholar 

  6. Takahashi M, Nishizawa T, Nagashima S, Jirintai S, Kawakami M, Sonoda Y, et al. Molecular characterization of a novel hepatitis E virus (HEV) strain obtained from a wild boar in Japan that is highly divergent from the previously recognized HEV strains. Virus Res. 2014;180:59–69.

    CAS  Article  Google Scholar 

  7. Takahashi M, Nishizawa T, Sato H, Sato Y, Jirintai NS, Okamoto H. Analysis of the full-length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol. 2011;92:902–8.

    CAS  Article  Google Scholar 

  8. Woo PC, Lau SK, Teng JL, Cao KY, Wernery U, Schountz T, et al. New Hepatitis E Virus Genotype in Bactrian Camels, Xinjiang, China, 2013. Emerg Infect Dis. 2016;22:2219–21.

    CAS  Article  Google Scholar 

  9. Woo PC, Lau SK, Teng JL, Tsang AK, Joseph M, Wong EY, et al. New hepatitis E virus genotype in camels, the Middle East. Emerg Infect Dis. 2014;20:1044–8.

    Article  Google Scholar 

  10. Liu P, Li L, Wang L, Bu Q, Fu H, Han J, et al. Phylogenetic analysis of 626 hepatitis E virus (HEV) isolates from humans and animals in China (1986-2011) showing genotype diversity and zoonotic transmission. Infect Genet Evol. 2012;12:428–34.

    CAS  Article  Google Scholar 

  11. Tian H, Fu X, Li W, Huang Y, Sun J, Zhou G, et al. Genotype 4 Hepatitis E Virus Prevalent in Eastern China Shows Diverse Subtypes. Hepat Mon. 2015;15:e25367.

    Article  Google Scholar 

  12. Wang XJ, Zhao Q, Jiang FL, Liu BY, Zhao JN, Dang L, et al. Genetic characterization and serological prevalence of swine hepatitis E virus in Shandong province. China. Vet Microbiol. 2014;172:415–24.

    CAS  Article  Google Scholar 

  13. Li H, Wu J, Sheng Y, Lu Q, Liu B, Chen Y, et al. Prevalence of hepatitis E virus (HEV) infection in various pig farms from Shaanxi Province, China: First detection of HEV RNA in pig semen. Transbound Emerg Dis. 2019;66:72–82.

    CAS  Article  Google Scholar 

  14. Wang L, Zhang Y, Gong W, Song WT, Wang L. Hepatitis E Virus in 3 Types of Laboratory Animals, China, 2012-2015. Emerg Infect Dis. 2016;22:2157–9.

    Article  Google Scholar 

  15. McCaustland KA, Krawczynski K, Ebert JW, Balayan MS, Andjaparidze AG, Spelbring JE, et al. Hepatitis E virus infection in chimpanzees: a retrospective analysis. Arch Virol. 2000;145:1909–18.

    CAS  Article  Google Scholar 

  16. Meng XJ, Halbur PG, Haynes JS, Tsareva TS, Bruna JD, Royer RL, et al. Experimental infection of pigs with the newly identified swine hepatitis E virus (swine HEV), but not with human strains of HEV. Arch Virol. 1998;143:1405–15.

    CAS  Article  Google Scholar 

  17. Liu B, Chen Y, Sun Y, Nan Y, Li H, Du T, et al. Experimental infection of rabbit with swine-derived hepatitis E virus genotype 4. Vet Microbiol. 2019;229:168–75.

    CAS  Article  Google Scholar 

  18. Cao D, Cao QM, Subramaniam S, Yugo DM, Heffron CL, Rogers AJ, et al. Pig model mimicking chronic hepatitis E virus infection in immunocompromised patients to assess immune correlates during chronicity. Proc Natl Acad Sci U S A. 2017;114:6914–23.

    CAS  Article  Google Scholar 

  19. Bremer W, Blasczyk H, Yin X, Salinas E, Grakoui A, Feng Z, et al. Resolution of hepatitis E virus infection in CD8+ T cell-depleted rhesus macaques. J Hepatol. 2021;75:557–64.

    CAS  Article  Google Scholar 

  20. Tang ZM, Wang SL, Ying D, Wen GP, Cai W, Zhang K, et al. The Bama miniature swine is susceptible to experimental HEV infection. Sci Rep. 2016;6:31813.

    CAS  Article  Google Scholar 

  21. Zhou J, Huang F, Hua X, Cui L, Zhang W, Shen Y, et al. Inhibition of porcine transmissible gastroenteritis virus (TGEV) replication in mini-pigs by shRNA. Virus Res. 2010;149:51–5.

    CAS  Article  Google Scholar 

  22. Zhou K, Zhou Q, Yang D, Yue H, Tang C, Zhang B. Hepatitis E virus in Tibetan pigs on the Qinghai-Tibetan Plateau: detection, molecular characterization and infection of BALB/c mice. Arch Virol. 2019;164:2943–51.

    CAS  Article  Google Scholar 

  23. Liu B, Chen Y, Zhao L, Zhang M, Ren X, Zhang Y, et al. Identification and pathogenicity of a novel genotype avian hepatitis E virus from silkie fowl (gallus gallus). Vet Microbiol. 2020;245:108688.

    CAS  Article  Google Scholar 

  24. Sooryanarain H, Meng XJ. Swine hepatitis E virus: Cross-species infection, pork safety and chronic infection. Virus Res. 2020;284:197985.

    CAS  Article  Google Scholar 

  25. Allweiss L, Gass S, Giersch K, Groth A, Kah J, Volz T, et al. Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation. J Hepatol. 2016;64:1033–40.

    CAS  Article  Google Scholar 

  26. Johne R, Plenge-Bonig A, Hess M, Ulrich RG, Reetz J, Schielke A. Detection of a novel hepatitis E-like virus in faeces of wild rats using a nested broad-spectrum RT-PCR. J Gen Virol. 2010;91:750–8.

    CAS  Article  Google Scholar 

  27. Huang FF, Haqshenas G, Guenette DK, Halbur PG, Schommer SK, Pierson FW, et al. Detection by reverse transcription-PCR and genetic characterization of field isolates of swine hepatitis E virus from pigs in different geographic regions of the United States. J Clin Microbiol. 2002;40:1326–32.

    CAS  Article  Google Scholar 

  28. Kasorndorkbua C, Halbur PG, Thomas PJ, Guenette DK, Toth TE, Meng XJ. Use of a swine bioassay and a RT-PCR assay to assess the risk of transmission of swine hepatitis E virus in pigs. J Virol Methods. 2002;101:71–8.

    CAS  Article  Google Scholar 

  29. Ma H, Zheng L, Liu Y, Zhao C, Harrison TJ, Ma Y, et al. Experimental infection of rabbits with rabbit and genotypes 1 and 4 hepatitis E viruses. PLoS One. 2010;5:e9160.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank our funding sources.

Funding

The study was supported by grants from National Natural Science Foundation of China (No. 31720103919) to EMZ and Chinese Universities Scientific Fund (No. 2452019220) to BYL, Natural Science Foundation of Shannxi Province (No. 2020JQ-268) to BYL.

Author information

Affiliations

Authors

Contributions

BYL and YYC performed the experiment, arranged the data and drafted the manuscript. MMZ, TXC and YZ analyzed the data. BYL, DBZX and SXX collected the clinical samples. QZ and EMZ revised the manuscript. All of the authors read and approved the final manuscript.

Corresponding authors

Correspondence to Baoyuan Liu or En-Min Zhou.

Ethics declarations

Ethics approval and consent to participate

All animal experiments were carried out according to the Guidance for Experimental Animal Welfare and Ethical Treatment by the Ministry of Science and Technology of China. The protocols were approved by the Committee on Ethical Use of Animals of Northwest A&F University (AE124323). All methods are used in the study is accordance with ARRIVE guidelines for the reporting of animal experiments.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Liu, B., Chen, Y., Zhang, M. et al. Identification and pathogenicity of hepatitis E Virus from laboratory Bama miniature pigs. BMC Vet Res 18, 99 (2022). https://doi.org/10.1186/s12917-022-03206-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12917-022-03206-7

Keywords

  • Hepatitis E virus
  • Bama miniature pig
  • Sequence analysis
  • Pathogenicity